JP2010514798A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514798A5
JP2010514798A5 JP2009544280A JP2009544280A JP2010514798A5 JP 2010514798 A5 JP2010514798 A5 JP 2010514798A5 JP 2009544280 A JP2009544280 A JP 2009544280A JP 2009544280 A JP2009544280 A JP 2009544280A JP 2010514798 A5 JP2010514798 A5 JP 2010514798A5
Authority
JP
Japan
Prior art keywords
groups
npl
polar
substituted
nonpolar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009544280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010514798A (ja
JP5512279B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/089001 external-priority patent/WO2008083256A2/en
Publication of JP2010514798A publication Critical patent/JP2010514798A/ja
Publication of JP2010514798A5 publication Critical patent/JP2010514798A5/ja
Application granted granted Critical
Publication of JP5512279B2 publication Critical patent/JP5512279B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009544280A 2006-12-29 2007-12-28 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用 Expired - Fee Related JP5512279B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88280006P 2006-12-29 2006-12-29
US60/882,800 2006-12-29
PCT/US2007/089001 WO2008083256A2 (en) 2006-12-29 2007-12-28 Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014061503A Division JP5745666B2 (ja) 2006-12-29 2014-03-25 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用

Publications (3)

Publication Number Publication Date
JP2010514798A JP2010514798A (ja) 2010-05-06
JP2010514798A5 true JP2010514798A5 (https=) 2010-09-16
JP5512279B2 JP5512279B2 (ja) 2014-06-04

Family

ID=39589209

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009544280A Expired - Fee Related JP5512279B2 (ja) 2006-12-29 2007-12-28 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用
JP2014061503A Expired - Fee Related JP5745666B2 (ja) 2006-12-29 2014-03-25 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014061503A Expired - Fee Related JP5745666B2 (ja) 2006-12-29 2014-03-25 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用

Country Status (12)

Country Link
US (5) US20090092574A1 (https=)
EP (1) EP2114395B1 (https=)
JP (2) JP5512279B2 (https=)
CN (3) CN101631543B (https=)
AU (1) AU2007339790B2 (https=)
CA (1) CA2674080C (https=)
DK (1) DK2114395T3 (https=)
ES (1) ES2538479T3 (https=)
HU (1) HUE025868T2 (https=)
PL (1) PL2114395T3 (https=)
PT (1) PT2114395E (https=)
WO (1) WO2008083256A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207211A1 (en) * 2003-04-10 2007-09-06 Pr Pharmaceuticals, Inc. Emulsion-based microparticles and methods for the production thereof
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
RU2530899C2 (ru) * 2008-07-28 2014-10-20 Селлсьютикс Корпорейшн Противомалярийные соединения
TWI478915B (zh) * 2008-10-27 2015-04-01 Cellceutix Corp 宿主防禦之合成模擬物及其用途
ITTO20090131A1 (it) * 2009-02-24 2010-08-25 Liofarmaceutici Srl Composizioni oftalmiche contenenti teicoplanina
CA2804666A1 (en) * 2010-07-07 2012-01-12 Polymedix, Inc. Methods of immune modulation
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
DK2709619T3 (en) 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS
TW202126313A (zh) * 2011-09-16 2021-07-16 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物
KR20140129030A (ko) * 2012-01-18 2014-11-06 셀슈틱스 코포레이션 캔디다증 및 아스퍼질러스 감염을 치료하기 위한 화합물 및 방법
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
JP6047203B2 (ja) * 2015-02-20 2016-12-21 セルセウティックス コーポレイション 消化管の炎症性疾患の予防および／または治療のための宿主防御タンパク質（ｈｄｐ）模倣薬
EA201890633A1 (ru) 2015-09-03 2018-09-28 Зе Администрейторс Оф Зе Тьюлейн Эдьюкейшнл Фанд Композиции и способы для многофункциональных растворов для дезинфекции и стерилизации
EP3478654A4 (en) * 2016-07-01 2020-02-26 Boulos&Cooper Pharmaceuticals PTY Ltd NEW ANTIBIOTICS
IT201900000561A1 (it) * 2019-01-14 2020-07-14 Medivis S R L Formulazioni topiche oftalmiche chimicamente e fisicamente stabili a base di Nepafenac
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
US12102622B2 (en) 2021-02-10 2024-10-01 Iolyx Therapeutics, Inc. Methods for ophthalmic delivery of roflumilast
WO2023049809A1 (en) 2021-09-22 2023-03-30 Iolyx Therapeutics, Inc. Methods of treating ocular inflammatory diseases

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496179A (en) * 1967-10-11 1970-02-17 Pfizer & Co C 2-amino-3,4-dihydroquinazolines
SE352811B (https=) 1971-06-04 1973-01-15 Pharmacia Ab
US3960150A (en) 1971-09-09 1976-06-01 Alza Corporation Bioerodible ocular device
US3867519A (en) 1972-04-27 1975-02-18 Alza Corp Bioerodible drug delivery device
SE375007B (https=) 1972-11-30 1975-04-07 Pharmacia Ab
US3914402A (en) 1973-06-14 1975-10-21 Alza Corp Ophthalmic dosage form, for releasing medication over time
US3963025A (en) 1974-09-16 1976-06-15 Alza Corporation Ocular drug delivery device
US4186184A (en) 1977-12-27 1980-01-29 Alza Corporation Selective administration of drug with ocular therapeutic system
US4303637A (en) 1980-04-04 1981-12-01 Alza Corporation Medication indicated for ocular hypertension
US4559343A (en) 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US5223492A (en) 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
US5190927A (en) 1991-07-09 1993-03-02 Merck & Co., Inc. High-glyceryl, low-acetyl gellan gum for non-brittle gels
EP0629347B1 (en) * 1992-01-23 1997-07-02 Morinaga Milk Industry Co., Ltd. Antibacterial agent and treatment of article therewith
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
KR100439006B1 (ko) 1994-08-30 2005-04-06 파마시아 에이비 안과 치료용 장치,치료액체를 방출시키는 방법 및 액체 투여액용 패키지
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6025326A (en) 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
US5994306A (en) 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
JP3090125B2 (ja) * 1997-08-26 2000-09-18 千寿製薬株式会社 ソフトコンタクトレンズ用の眼科用組成物、ソフトコンタクトレンズの濡れ増強方法およびテルペノイドの吸着抑制方法
AU758563B2 (en) * 1998-08-20 2003-03-27 University Of North Carolina At Chapel Hill, The Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
US6482799B1 (en) * 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
JP2001261674A (ja) * 2000-03-22 2001-09-26 Mitsui Chemicals Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬
FR2813080B1 (fr) * 2000-08-17 2002-11-29 Stago Diagnostica Peptides anti-heparine
US20060078626A1 (en) * 2000-11-08 2006-04-13 Bioconcept Laboratories Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
US20030021761A1 (en) 2001-01-18 2003-01-30 Geltex Pharmaceuticals, Inc. Ionene polymers and their use in treating mucositis
ES2314087T3 (es) * 2001-03-08 2009-03-16 The Trustees Of The University Of Pennsylvania Polimeros facialmente anfifilicos como agentes antiinfecciosos.
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
AU2002341566A1 (en) 2001-08-16 2003-04-01 Mucosal Therapeutics, Inc. Treatment and prevention of mucositis in cancer patients
EP1535235A1 (en) * 2002-05-28 2005-06-01 The Trustees of The University of Pennsylvania Methods, systems, and computer program products for computational analysis and design of amphiphilic polymers
JP2005529604A (ja) * 2002-06-13 2005-10-06 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 粗粒度モデルを用いる生体膜をシミュレートするための方法、システム、およびコンピュータプログラム製品
AU2003291087A1 (en) 2002-11-19 2004-06-15 Genzyme Corporation Ionene oligomers and polymers
WO2004082634A2 (en) * 2003-03-17 2004-09-30 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof
AU2003249114A1 (en) 2003-03-20 2004-10-11 Shiseido International France Cosmetic composition
US20040202687A1 (en) * 2003-04-14 2004-10-14 Babu M.K. Manoj Ciprofloxacin formulations and methods of making and using the same
US20050065091A1 (en) * 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
JP5260877B2 (ja) * 2004-01-23 2013-08-14 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 面に対して両親媒性のポリアリール及びポリアリールアルキニルのポリマー及びオリゴマー並びにそれらの使用
KR101172722B1 (ko) 2004-06-15 2012-08-16 폴리메딕스, 인코포레이티드 다가양이온성 화합물 및 이의 용도
AU2005332637B2 (en) * 2004-07-23 2011-04-07 The Trustees Of The University Of Pennsylvania Antimicrobial copolymers and uses thereof
CA2599205A1 (en) * 2005-02-25 2006-09-08 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
ES2351665T3 (es) 2005-03-24 2011-02-09 Rottapharm S.P.A. Derivados de benzamidina para el tratamiento y la prevención de mucositis.
AU2006244080C1 (en) 2005-05-10 2012-02-02 The University Of Chicago Use of peptides derived from the growth factor AMP-18 for the treatment of mucositis
US7951829B2 (en) 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1
JP2008137978A (ja) * 2006-12-05 2008-06-19 Canon Inc カルバゾール誘導体及びこれを用いた有機発光素子
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
US20100297257A1 (en) 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
RU2530899C2 (ru) 2008-07-28 2014-10-20 Селлсьютикс Корпорейшн Противомалярийные соединения
TWI478915B (zh) * 2008-10-27 2015-04-01 Cellceutix Corp 宿主防禦之合成模擬物及其用途
EP2389067A4 (en) 2008-12-10 2012-06-13 Polymedix Inc ANTIMICROBIAL MOLECULES FOR THE TREATMENT OF MYCOBACTERIUM STRAINS WITH MULTIDRUG RESISTANCE AND LARGE RESISTANCE TO DRUGS
UA110323C2 (en) 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
US20110178104A1 (en) * 2010-01-07 2011-07-21 Polymedix Inc. Anti-Heparin Compounds
TW201208677A (en) 2010-08-21 2012-03-01 Polymedix Inc Facially amphiphilic compounds, compositions, and uses thereof in treating cancer
DK2709619T3 (en) 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS
KR20140129030A (ko) 2012-01-18 2014-11-06 셀슈틱스 코포레이션 캔디다증 및 아스퍼질러스 감염을 치료하기 위한 화합물 및 방법
WO2014093231A2 (en) 2012-12-10 2014-06-19 Cellceutix Corporation Hybrid compounds and methods of making and using the same
WO2014093225A2 (en) 2012-12-10 2014-06-19 Cellceutix Corporation Polycyclic compounds and methods of making and using the same
US9993469B2 (en) 2013-05-28 2018-06-12 Morphochem Aktiengesellschaft Für Kombinatorishe Chemie Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
JP6047203B2 (ja) 2015-02-20 2016-12-21 セルセウティックス コーポレイション 消化管の炎症性疾患の予防および／または治療のための宿主防御タンパク質（ｈｄｐ）模倣薬

Similar Documents

Publication Publication Date Title
JP2010514798A5 (https=)
CA2674080C (en) Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof
WO2007108541A1 (ja) キサンタンガムおよびブドウ糖を含有する眼科用組成物
JP2002525317A5 (https=)
JP2006521355A5 (https=)
JP2012520882A5 (https=)
US20030055051A1 (en) Ophthalmic aqueous pharmaceutical preparation
US11890375B2 (en) Ophthalmic solution of difluprednate
CA2660151A1 (en) Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
JP5925823B2 (ja) ヒアルロン酸又はその薬学的に許容される塩を含む保存組成物及び関連する方法
WO2010150812A1 (ja) 眼科用組成物及び白濁・沈殿抑制方法
JP2008531585A5 (https=)
JP4725699B2 (ja) 眼科用組成物及び眼科用組成物配合用防腐剤
KR20170093816A (ko) 녹내장을 예방 또는 치료하기 위한 약물 요법
JPWO2015125921A1 (ja) 保存効力を有する医薬用水性組成物
JPH1192368A (ja) ベンゾピラン誘導体を主成分とする水性液剤
EP1876175B1 (en) Therapeutic agent for corneal disease
JP4470393B2 (ja) 安定である点眼剤
AU2013242820A1 (en) Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof